Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 1
1960 1
1962 2
1964 1
1965 7
1966 21
1967 16
1968 17
1969 11
1970 20
1971 18
1972 18
1973 13
1974 14
1975 12
1976 13
1977 12
1978 16
1979 24
1980 30
1981 23
1982 26
1983 42
1984 27
1985 34
1986 29
1987 33
1988 34
1989 24
1990 52
1991 58
1992 30
1993 35
1994 38
1995 31
1996 34
1997 33
1998 51
1999 46
2000 36
2001 53
2002 47
2003 51
2004 59
2005 52
2006 58
2007 57
2008 67
2009 86
2010 83
2011 79
2012 91
2013 123
2014 128
2015 101
2016 100
2017 106
2018 127
2019 99
2020 80
2021 111
2022 56
2023 59
2024 78
2025 83
2026 54

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,800 results

Results by year

Filters applied: . Clear all
Page 1
Systemic mastocytosis in adults: 2023 update on diagnosis, risk stratification and management.
Pardanani A. Pardanani A. Am J Hematol. 2023 Jul;98(7):1097-1116. doi: 10.1002/ajh.26962. Epub 2023 May 22. Am J Hematol. 2023. PMID: 37309222 Free article.
OVERVIEW: Systemic mastocytosis (SM) results from clonal proliferation of mast cells (MC) in extracutaneous organs. ...
OVERVIEW: Systemic mastocytosis (SM) results from clonal proliferation of mast cells (MC) in extracutaneous organs. ...
Systemic mastocytosis: 2023 update on diagnosis and management in adults.
Costa A, Scalzulli E, Carmosino I, Capriata M, Ielo C, Masucci C, Passucci M, Martelli M, Breccia M. Costa A, et al. Expert Opin Emerg Drugs. 2023 Dec;28(3):153-165. doi: 10.1080/14728214.2023.2221028. Epub 2023 Jun 6. Expert Opin Emerg Drugs. 2023. PMID: 37256917 Review.
INTRODUCTION: Systemic mastocytosis (SM) is a complex and heterogeneous disease, characterized by the clonal accumulation of mast cells in one or more organs. ...
INTRODUCTION: Systemic mastocytosis (SM) is a complex and heterogeneous disease, characterized by the clonal accumulation of mast cel …
Systemic mastocytosis in adults: 2021 Update on diagnosis, risk stratification and management.
Pardanani A. Pardanani A. Am J Hematol. 2021 Apr 1;96(4):508-525. doi: 10.1002/ajh.26118. Epub 2021 Feb 21. Am J Hematol. 2021. PMID: 33524167 Free article. Review.
OVERVIEW: Systemic mastocytosis (SM) results from a clonal proliferation of abnormal mast cells (MC) in extra-cutaneous organs. ...
OVERVIEW: Systemic mastocytosis (SM) results from a clonal proliferation of abnormal mast cells (MC) in extra-cutaneous organs. ...
Cutaneous Mastocytosis in Adults and Children: New Classification and Prognostic Factors.
Matito A, Azaña JM, Torrelo A, Alvarez-Twose I. Matito A, et al. Immunol Allergy Clin North Am. 2018 Aug;38(3):351-363. doi: 10.1016/j.iac.2018.04.001. Epub 2018 May 17. Immunol Allergy Clin North Am. 2018. PMID: 30007456 Review.
The skin is one of the most frequent tissues affected in patients with mastocytosis, but cutaneous lesions are highly heterogeneous in shape, size, color, number, localization, and distribution. The World Health Organization recognizes 3 subtypes of cutaneous mastocytos …
The skin is one of the most frequent tissues affected in patients with mastocytosis, but cutaneous lesions are highly heterogeneous i …
Systemic Mastocytosis in Adults: 2026 Update on Diagnosis, Risk Stratification and Management.
Pardanani A. Pardanani A. Am J Hematol. 2026 Sep;101(9):2371-2392. doi: 10.1002/ajh.70395. Epub 2026 Jun 17. Am J Hematol. 2026. PMID: 42310859 Free PMC article. Review.
OVERVIEW: Systemic mastocytosis (SM) results from clonal proliferation of mast cells (MC) in extra-cutaneous organs. ...
OVERVIEW: Systemic mastocytosis (SM) results from clonal proliferation of mast cells (MC) in extra-cutaneous organs. ...
Mastocytosis in the Skin: Approach to Diagnosis, Evaluation, and Management in Adult and Pediatric Patients.
Madigan LM, Boggs NA, Rets AV, Gru AA, Tashi T, Wada DA, Florell SR, Carter MC. Madigan LM, et al. Am J Clin Dermatol. 2025 Jul;26(4):499-510. doi: 10.1007/s40257-025-00947-7. Epub 2025 May 20. Am J Clin Dermatol. 2025. PMID: 40392511 Free PMC article. Review.
Mastocytosis is characterized by the clonal infiltration and proliferation of neoplastic mast cells into target organs. ...Cutaneous involvement is further categorized into cutaneous mastocytoma, diffuse cutaneous mastocytosis, and maculopapular cutaneous mastocy …
Mastocytosis is characterized by the clonal infiltration and proliferation of neoplastic mast cells into target organs. ...Cutaneous …
Diagnosis of Mastocytosis in Children and Adults in Daily Clinical Practice.
Lange M, Ługowska-Umer H, Niedoszytko M, Wasąg B, Limon J, Żawrocki A, Nedoszytko B, Sobjanek M, Plata-Nazar K, Nowicki R. Lange M, et al. Acta Derm Venereol. 2016 Mar;96(3):292-7. doi: 10.2340/00015555-2210. Acta Derm Venereol. 2016. PMID: 26270728 Free article. Review.
Clinical work-up consists of a combination of morphological, immunohistochemical, flow cytometric immunophenotyping and molecular examination. Cutaneous mastocytosis predominates in children, whereas systemic mastocytosis is the most common form of the disease in …
Clinical work-up consists of a combination of morphological, immunohistochemical, flow cytometric immunophenotyping and molecular examinatio …
How we diagnose and treat systemic mastocytosis in adults.
Scherber RM, Borate U. Scherber RM, et al. Br J Haematol. 2018 Jan;180(1):11-23. doi: 10.1111/bjh.14967. Epub 2017 Oct 19. Br J Haematol. 2018. PMID: 29048112 Review.
Rapid advances in the understanding of the molecular biology, data from translational and clinical trials, and retrospective analyses has influenced the diagnosis and treatment of systemic mastocytosis (SM). Many options have existed for the symptomatic management of SM pa …
Rapid advances in the understanding of the molecular biology, data from translational and clinical trials, and retrospective analyses has in …
French guidelines for the management of nonadvanced mastocytosis in adults.
Bulai Livideanu C, Barete S, Damaj G, Arock M, Rossignol J, Hermine O. Bulai Livideanu C, et al. Orphanet J Rare Dis. 2025 Oct 2;20(1):499. doi: 10.1186/s13023-025-03764-7. Orphanet J Rare Dis. 2025. PMID: 41039576 Free PMC article.
Its clinical features exhibit significant variability irrespective of its clinical presentation, classification, global survival or impact on quality of life (QOL). For example, 15% of adult patients present isolated skin mastocytosis, called cutaneous mastocytos …
Its clinical features exhibit significant variability irrespective of its clinical presentation, classification, global survival or impact o …
Systemic mastocytosis in adults: 2013 update on diagnosis, risk stratification, and management.
Pardanani A. Pardanani A. Am J Hematol. 2013 Jul;88(7):612-24. doi: 10.1002/ajh.23459. Epub 2013 May 30. Am J Hematol. 2013. PMID: 23720340 Free article. Review.
DISEASE OVERVIEW: Systemic mastocytosis (SM) results from a clonal proliferation of abnormal mast cells (MC) in one or more extracutaneous organs. ...
DISEASE OVERVIEW: Systemic mastocytosis (SM) results from a clonal proliferation of abnormal mast cells (MC) in one or more extracuta …
2,800 results